ADVDrug Header BOS 2018

Please join us at the 3rd Advancing Drug Development Forum -  Making the Impossible Possible scheduled to take place December 6th, 2018 at the Liberty Hotel, in Boston, Massachusetts from 8:30 AM – 8:30 PM.

WHEN:

Thursday,
December 6, 2018
8:30 AM - 8:30 PM

WHERE:

The Liberty Hotel
215 Charles Street
Boston, MA 02114

SPEAKERS & AGENDA AT-A-GLANCE

portrait-clive-patience-300×300

Clive Patience,
SVP Technical Operations,
Agios Pharmaceuticals

mary-lynn-hedley2

Mary Lynne Hedley, Ph.D.,
President, CEO & COO,
TESARO

Trish Hurter

Patricia Hurter, PhD.,
Senior VP, Pharmaceutical Executive, Chemical Engineer, Drug Discovery and Development,
Vertex Pharmaceuticals

And Many Others...

  • Janice Bourque, Managing Director, Life Sciences, Hercules Technology Growth Capital
  • Linda Bentley, Member, Mintz Levin
  • Alexandros Makriyannis, PhD, George D Behrakis Chair, Chemistry and Chemical Biology, College of Science - Chemistry and Chemical Biology, Northeastern University
  • Alok Tayi, CEO, Tetrascience
  • Mark Ashwell, VP Chemistry, Nimbus Therapeutics

WHO SHOULD ATTEND?

The event is specifically designed to bring a focused group of key opinion leaders, decision makers, senior scientists, c-suite executives, innovators and early adopters who are deeply involved in small molecule formulation development, CMC, drug product, drug substance and API manufacturing. Attendees with expertise and focus on implementation of (new) technologies that accelerate development and improve quality and the regulatory process are encouraged to attend in order to exchange ideas and experiences.

ABOUT

The 3rd Advancing Drug Development Forum -  Making the Impossible Possible, builds on positive momentum and energy from the inaugural event that took place in Boston last year.

These forums are designed to allow free-flowing dialogue and plenty of time has been woven throughout the day to assure quality interactive networking.

It strives to attract and stimulate dialogue among key opinion leaders within in biotech and pharma, executive leaders, senior directors, consultants, and a close network of non-competitive CROs and CDMOs to further explore novel solutions, and promising technology breakthroughs. Together we will learn from entrepreneurial industry experts about how  they are introducing and incorporating novel approaches in small molecule drug development; changing time lines and ROIs.  Hear for yourself, how you can speed up your time lines and improve your product quality.

The program will include two keynote presentations, several provocative and focused panel discussions and plenty of opportunity for inactive dialogue between faculty and attendees.  It is imperative that that everyone comes open-minded,  ready to explore and share various approaches, so that together we can find better ways to break down barriers and improve upon past methods for developing complex drug formulation and manufacturing.

Within our scope, we will learn better ways to learn to communicate, form strong relationships, and work seamlessly together.  Together  we will discuss how critical it is to invest our resources with the right partners to break down barriers, and meet the demands and expectations towards developing high quality products.

This forum will explore better ways to face the many new challenges that still lie ahead, and search for better solutions that employ entrepreneurial and novel technologies in order to development important complex compounds to treat unmet medical conditions.

See you December 6th 2018 at the Liberty Hotel in Boston, MA

EXHIBITORS & SPONSORS

Catalent
pion
tetrascience logo
foster delivery science
nucleo
logo-animated-2

WHAT YOUR PEERS ARE SAYING ABOUT THE ADVANCING DRUG DEVELOPMENT FORUM

Thank you for inviting us to participate. It was great to have an open dialogue with open minded peers in the industry. We do agree it must be a part of your next event in Boston!

Lara Park-Menning, MSc. PMP COO and Head of Project Management Nucleo Life Sciences

I had a wonderful time at the meeting ...and I am looking forward to the December meeting in Boston. Although It will be hard to top the great wine testings and the venue.  Keep me informed!

Eyal S. Ron Consultant
I loved the meeting and most especially the openness by which people were communicating and looking for opportunities to work together!
Magali Hickey, Ph.D., Senior Director Alkermes